BeiGene is a clinical-stage Biopharma company focused on discovering and developing innovative, best-in-class, targeted and immuno-oncology drugs that address severe unmet medical needs in a variety of cancer indications.
Industries: Biotechnology
Health Care
Life Science
Medical
Investor Types: Venture Capital
Private Equity Firm
Location: Changping, Beijing, China